The Indian army has published a tender for "FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ ERYTHROPOIETIN RECOMBINANT HUMAN 5000 IU,INJ ERYTHROPOIETIN RECOMBINANT HUMAN 5000 IU,INJ ERYTHROPOIETIN RECOMBINANT HUMAN 5000 IU,INJ ERYTHROPOIETIN RECOMBINANT HUMAN 50" on the 10 Nov 2025. This tender belongs to Medicines category. This tender is published in New Delhi, Delhi location. The vendors interested in this tender and related Medicines tenders can obtain further details by exploring Tendersniper web portal. Tendersniper sends regular tender alerts by email specifically addressing the user requirements (i.e., keywords, location and value range). Government business is a growing area of opportunity. The businesses are encouraged to actively monitor tender opportunities and participate in them to grow their business.
Related alert: hospital supply Tenders | pharmacy medicines Tenders | all types of buoys Tenders
Delhi has published 2,557 tenders in Medicines in the last financial year.
Out of these, 109 were published last month.
| Tender Title | FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,FILGRASTIM 300 MCG INJ,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ ANTIHEMOPHILIC 500 UNIT FACTOR VIII,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ DARBEPOETIN 60 MG,INJ ERYTHROPOIETIN RECOMBINANT HUMAN 5000 IU,INJ ERYTHROPOIETIN RECOMBINANT HUMAN 5000 IU,INJ ERYTHROPOIETIN RECOMBINANT HUMAN 5000 IU,INJ ERYTHROPOIETIN RECOMBINANT HUMAN 50 |
|---|---|
| Tender Description | filgrastim 300 mcg inj , inj antihemophilic 500 unit factor viii , inj darbepoetin 60 mg , inj erythropoietin recombinant human 5000 iu , insulin lispro biphasic 50 per 50 per insulin lispro and 50 /item category per insuline lispro protamine suspension 100iuml 3ml cart humalog mix 50 3ml cart , mesalamine 1 gm sachet , methylcobalamin 500mg tab , mycophenolate sodium 250mg tab , nintedanib 150 mg cap , olmesartan 40 mg tab filgrastim 300 mcg inj, inj antihemophilic 500 unit factor viii, inj darbepoetin 60 mg, inj erythropoietin recombinant human 5000 iu, insulin lispro biphasic |
| Comments | filgrastim 300 mcg inj , inj antihemophilic 500 unit factor viii , inj darbepoetin 60 mg , inj erythropoietin recombinant human 5000 iu , insulin lispro biphasic 50 per 50 per insulin lispro and 50 /item category per insuline lispro protamine suspension 100iuml 3ml cart humalog mix 50 3ml cart , mesalamine 1 gm sachet , methylcobalamin 500mg tab , mycophenolate sodium 250mg tab , nintedanib 150 mg cap , olmesartan 40 mg tab filgrastim 300 mcg inj, inj antihemophilic 500 unit factor viii, inj darbepoetin 60 mg, inj erythropoietin recombinant human 5000 iu, insulin lispro biphasic |
| Published Date | |
|---|---|
| Due Date | 25 Nov 2025 00:00:00 |
| Estimated Value | 0.0 |
|---|---|
| EMD | 0 INR |
| Processing Fee | 0 INR |